tiprankstipranks
Corcept Therapeutics Inc. (CORT)
NASDAQ:CORT
US Market

Corcept Therapeutics (CORT) Income Statement

Compare
838 Followers

Corcept Therapeutics Income Statement

Last quarter (Q3 2024), Corcept Therapeutics's total revenue was $182.55M, an increase of 47.69% from the same quarter last year. In Q3, Corcept Therapeutics's net income was $46.69M. See Corcept Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 482.38M$ 401.86M$ 365.98M$ 353.87M$ 306.49M
Gross Profit
$ 475.89M$ 396.47M$ 360.70M$ 348.29M$ 300.98M
Operating Expenses
$ 368.61M$ 283.84M$ 236.22M$ 220.09M$ 189.38M
Depreciation and Amortization
$ 1.04M$ 2.97M$ 3.07M$ 2.24M$ 2.17M
EBITDA
$ 108.32M$ 112.63M$ 124.48M$ 130.44M$ 113.78M
Operating Income
$ 107.28M$ 112.63M$ 124.48M$ 128.20M$ 111.61M
Other Income/Expenses
$ 17.27M$ 3.56M$ 529.00K$ 3.40M$ 5.07M
Pretax Income
$ 124.56M$ 116.19M$ 125.01M$ 131.60M$ 116.68M
Net Income
$ 106.14M$ 101.42M$ 112.51M$ 106.01M$ 94.18M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ 1.02$ 0.95$ 0.97$ 0.92$ 0.82
Diluted EPS
$ 0.94$ 0.87$ 0.89$ 0.85$ 0.77
Weighted Average Shares Outstanding
103.56M 106.79M 115.65M 115.41M 114.35M
Weighted Average Shares Outstanding (Diluted)
111.74M 115.97M 125.96M 124.19M 122.57M
Currency in USD

Corcept Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis